Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia. 1987

A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
Department of Child Health, University of Newcastle upon Tyne, England.

Repeated methotrexate absorption studies were performed under standard conditions in 127 children receiving either oral or intramuscular methotrexate for acute lymphoblastic leukaemia. There was marked variability in peak concentration, area under the serum concentration curve and clearance both between patients and in repeated studies on the same patient. Although the intramuscular route produced higher serum concentrations and AUC than the oral route, variability within and between patients was considerable and was most marked at higher concentrations. Neither age or sex could account for variation in methotrexate absorption or clearance. Intramuscular methotrexate, although producing higher serum concentrations and AUC, does not reduce the variability observed with oral administration. Prediction of subsequent methotrexate concentrations from the knowledge of one absorption profile is not possible.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females

Related Publications

A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
January 2006, Clinical pharmacokinetics,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
January 1979, Cancer chemotherapy and pharmacology,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
February 1987, Archives of disease in childhood,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
December 1977, British medical journal,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
October 1988, Boletin medico del Hospital Infantil de Mexico,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
January 1989, Cancer chemotherapy and pharmacology,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
April 2011, Journal of clinical pharmacy and therapeutics,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
December 1982, Cancer chemotherapy and pharmacology,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
March 2022, Xenobiotica; the fate of foreign compounds in biological systems,
A D Pearson, and S Mills, and H A Amineddine, and D R Long, and A W Craft, and J M Chessells
April 1990, Archives of disease in childhood,
Copied contents to your clipboard!